Time to incorporate time in cost-effectiveness analysis

被引:17
作者
van de Wetering, Gijs [1 ]
Woertman, Willem H. [1 ]
Adang, Eddy M. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Med Ctr, NL-6500 HB Nijmegen, Netherlands
关键词
Time; Economic evaluation; Short run; Cost-effectiveness; DECISION-MAKING; ECONOMIC-EVALUATION; CARE;
D O I
10.1007/s10198-011-0374-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health care technologies.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 13 条
[1]  
[Anonymous], MANUAL COSTING RES M
[2]  
Bakker A.M., 2006, DIGITALISERING BEVOL
[3]  
Berger M L, 1999, Jt Comm J Qual Improv, V25, P455
[4]   Has the time come for cost-effectiveness analysis in US health care? [J].
Bryan, Stirling ;
Sofaer, Shoshanna ;
Siegelberg, Taryn ;
Gold, Marthe .
HEALTH ECONOMICS POLICY AND LAW, 2009, 4 (04) :425-443
[5]   Economic evaluation under managed competition: Evidence from the UK [J].
Drummond, M ;
Cooke, J ;
Walley, T .
SOCIAL SCIENCE & MEDICINE, 1997, 45 (04) :583-595
[6]  
Drummond Michael F., 2005, Methods for the Economic Evaluation of Health Care Programmes, V3rd
[7]   Research into the use of health economics in decision making in the United Kingdom - Phase II - Is health economics 'for good or evil?' [J].
Duthie, T ;
Trueman, P ;
Chancellor, J ;
Diez, L .
HEALTH POLICY, 1999, 46 (02) :143-157
[8]   Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment [J].
Hartman, M ;
Prins, M ;
Swinkels, OQJ ;
Severens, JL ;
De Boo, T ;
Van der Wilt, GJ ;
Van de Kerkhof, PCM ;
Van der Valk, PGM .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (03) :538-544
[9]   The influence of economic evaluation studies on decision making. A European survey [J].
Hoffmann, C ;
von der Schulenburg, JMG .
HEALTH POLICY, 2000, 52 (03) :179-192
[10]  
Prosser LA, 2000, AM J MANAG CARE, V6, P173